SRDX
SURMODICS INCCompany Information
- Company Name
- SURMODICS INC
- CIK
- CIK0000924717
- Category
- Accelerated filer
- Ticker: Exchange
- SRDX: Nasdaq
- Fiscal Year End
- September 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SRDX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2024-11-26
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 7,009
Institutional Sentiment
- As of
- 2025-09-30
- Institutional shares owned
- 11,411,057
- Shares outstanding
- 14,281,000
- Ownership
- 79.90%
Earnings Market Reaction
- Filing date
- 2025-08-08
- Price on filing date
- —
- 1-month reaction
- -3.87%
- 3-month reaction
- -23.02%
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 26 | 29 | 30 | 36 | 24 | 33 | 23 | 41 | 45 | 19 | 26 | 19 | ||||||
| Available For Sale Securities Debt Securities Current | 6 | 2 | - | 4 | 14 | 8 | 12 | 4 | - | - | - | - | ||||||
| Accounts Receivable Net Current | 13 | 12 | 13 | 13 | 13 | 12 | 13 | 11 | 12 | 12 | 10 | 10 | ||||||
| Contract With Customer Asset Net | - | - | - | - | - | 11 | 9 | 8 | 8 | 8 | 7 | 7 | ||||||
| Contract With Customer Asset Net Current | 9 | 10 | 10 | 10 | 10 | - | - | 8 | - | - | - | - | ||||||
| Inventory Net | 16 | 16 | 15 | 15 | 15 | 15 | 14 | 15 | 15 | 14 | 13 | 12 | ||||||
| Income Taxes Receivable | 1 | - | - | - | - | 1 | 0 | 0 | - | - | 0 | 2 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 3 | 4 | 3 | 3 | 4 | 8 | 7 | 7 | 8 | 8 | 7 | ||||||
| Assets Current | 76 | 72 | 72 | 81 | 80 | 84 | 80 | 87 | 86 | 61 | 64 | 58 | ||||||
| Property Plant And Equipment Net | 23 | 23 | 24 | 25 | 25 | 26 | 26 | 26 | 27 | 28 | 28 | 27 | ||||||
| Intangible Assets Net Excluding Goodwill | 22 | 21 | 21 | 24 | 24 | 25 | 26 | 26 | 28 | 29 | 29 | 28 | ||||||
| Goodwill | 46 | 44 | 42 | 45 | 43 | 44 | 44 | 43 | 44 | 44 | 43 | 41 | ||||||
| Other Assets Noncurrent | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | ||||||
| Assets | 170 | 163 | 164 | 179 | 177 | 183 | 180 | 186 | 189 | 166 | 170 | 158 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 4 | 2 | 3 | ||||||
Accrued Liabilities Current | ||||||||||||||||||
| Employee Related Liabilities Current | 7 | 6 | 5 | 11 | 8 | 6 | 4 | 10 | 8 | 6 | 4 | 9 | ||||||
| Accrued Liabilities Current | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 5 | 6 | 7 | 6 | ||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | - | 10 | ||||||
| Deferred Revenue Current | 1 | 0 | 0 | 2 | 4 | 5 | 4 | 4 | 4 | 3 | 4 | 4 | ||||||
| Accrued Income Taxes Current | 0 | 0 | 2 | 1 | 0 | - | - | - | 12 | - | - | - | ||||||
| Liabilities Current | 19 | 14 | 13 | 21 | 20 | 19 | 16 | 24 | 32 | 19 | 17 | 32 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | - | 29 | - | ||||||
| Long Term Debt | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 | 29 | - | - | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | 2 | 2 | 3 | 3 | 4 | 5 | ||||||
| Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 8 | 10 | 10 | 10 | 11 | ||||||
| Liabilities | 59 | 53 | 52 | 60 | 59 | 59 | 58 | 66 | 76 | 64 | 62 | 50 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital Common Stock | 48 | 47 | 45 | 45 | 42 | 40 | 38 | 37 | 34 | 32 | 30 | 29 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | -4 | -6 | -2 | -4 | -4 | -3 | -5 | -3 | -4 | -5 | -10 | ||||||
| Retained Earnings Accumulated Deficit | 62 | 67 | 72 | 76 | 79 | 87 | 86 | 87 | 81 | 73 | 81 | 89 | ||||||
| Stockholders Equity | 111 | 110 | 112 | 119 | 118 | 124 | 122 | 120 | 112 | 103 | 107 | 108 | ||||||
| Liabilities And Stockholders Equity | 170 | 163 | 164 | 179 | 177 | 183 | 180 | 186 | 189 | 166 | 170 | 158 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | ||||||
| Common Stock Shares Authorized | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | ||||||
| Common Stock Shares Issued | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
| Shares Outstanding | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSURMODICS INC (SRDX) — SEC Financial Statements & Analysis
SURMODICS INC (SRDX) is a surgical & medical instruments & apparatus company, incorporated in MN. SURMODICS INC trades on Nasdaq as: SRDX. SURMODICS INC (SRDX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-08. Based on that filing, On profitability, SURMODICS INC posts a gross margin of 73.09%, an operating margin of -10.22%, a net margin of -14.59%, a Return on Equity (ROE) of -15.36%, a Return on Assets (ROA) of -10.15%, and a Return on Invested Capital (ROIC) of -10.17%. Per share, it reports EPS of $-1.23, diluted EPS of $-1.23, free cash flow per share of $-0.25, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -0.02% year-over-year, net income growth of 1159.97% year-over-year, and EPS growth of 1150.18% year-over-year. On the balance sheet, it maintains a current ratio of 3.91x, a quick ratio of 2.88x, working capital of $56.55M, a debt-to-equity ratio of 0.53x, a debt ratio of 0.34, an interest coverage ratio of -3.54x, free cash flow of $-3.55M (TTM), and net debt of $3.38M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-1.23
- ROE TTM
- -15.36%
- ROA TTM
- -10.15%
- Debt To Equity
- 0.53x
- Free Cash Flow TTM
- $-3.55M
- Net Revenue TTM Growth 1Y
- -0.02%
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SURMODICS INC in?
SURMODICS INC (SRDX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SRDX trade on?
SURMODICS INC (SRDX) trades on the Nasdaq.
Where is SURMODICS INC incorporated?
SURMODICS INC is incorporated in MN.
When was SURMODICS INC (SRDX)'s most recent SEC filing?
SURMODICS INC (SRDX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-08.
What is SRDX's EPS (earnings per share)?
SURMODICS INC (SRDX)'s trailing twelve month EPS is $-1.23 as of 2025-06-30.
What is SRDX's ROE (return on equity)?
SURMODICS INC (SRDX)'s trailing twelve month Return on Equity (ROE) is -15.36% as of 2025-06-30.
What is SRDX's ROA (return on assets)?
SURMODICS INC (SRDX)'s trailing twelve month Return on Assets (ROA) is -10.15% as of 2025-06-30.
What is SRDX's ROIC (return on invested capital)?
SURMODICS INC (SRDX)'s trailing twelve month Return on Invested Capital (ROIC) is -10.17% as of 2025-06-30.